AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Purple Biotech Ltd. Capital/Financing Update 2016

Dec 12, 2016

7004_rns_2016-12-12_18e50245-b44b-46c5-b332-f0efd084b57f.htm

Capital/Financing Update

Opens in your device viewer

_________ false


�� "�	2 352
KITOV PHARMACEUTICALS HOLDINGS LTD
Corporation no: 520031238	10994
- - -


	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	12/12/2016
	www.isa.gov.il			www.tase.co.il				Reference:	2016-02-138733	Time of broadcast: 17:52 17:48:29

Complementary report for a report sent on date 29/11/2016 whose reference number was 2016-02-133228


Main details added/ completed:	Form F-3 Registration Statement Under the Securities Act of 1933 - Draft Shelf Prospectus - updated draft following SEC comments

Immediate report on other matterDon't use this form if there is more adequate one


Form F-3 Registration Statement Under the Securities Act of 1933 - Draft Shelf Prospectus �� "� �� , �� . �� , �� . �� , �� , �� , ��
Attached file ff32016_kitovpharmaEDGAR4_Bannerless_isa.pdf



References of previous documents relating to this matter(the reference does not constitute incorporation by reference):


- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 31/10/2016
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 , Israel Tel: 03-9333121 , 03-9311321 Fax: 03-5097196
E-mail address: [email protected] Company site: www.kitovpharma.com

Previous names of reporting entity: MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,

Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company:
Address: Menachem Begin St, Azrieli Towers Round Tower 132, Floor 23 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: [email protected] 1
Israel